E-cadherin and beta-catenin expression in breast medullary carcinomas.

  • Authors:
    • C Charpin
    • P Bonnier
    • S Garcia
    • L Andrac
    • B Crebassa
    • M Dorel
    • M N Lavaut
    • C Allasia
  • View Affiliations

  • Published online on: August 1, 1999     https://doi.org/10.3892/ijo.15.2.285
  • Pages: 285-377
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The initial step of cancer invasion and metastasis is the escape of tumour cells from the primary site, involving disruption of normal cell-cell adhesion and E-cadherin (E-cad) and beta-catenin (beta-cat) down-regulation, as shown in various types of human malignancies including breast carcinomas. Medullary carcinomas are high grade and poorly differentiated tumours with syncytial typical pattern, and prognosis unexpectedly better than that in high grade breast carcinomas. In a series of 55 breast typical medullary carcinomas diagnosed according to the strict use of Ridolfi et al (Cancer 40: 1365-1385, 1977) criteria, E-cad and beta-cat were investigated using quantitative (SAMBA 2005 system) immunocytochemical assays on frozen sections. Results were compared to that obtained on paraffin sections and in a series (n=55) of grade 3 ductal carcinomas. It was shown that medullary carcinomas significantly (p<0.001) expressed more E-cad and beta-cat than grade 3 ductal carcinomas. E-cad and beta-cat correlated with high expression of P53, of c-erbB, and of Ki-67 antigens, and with lack of hormone receptors antigenic sites (p<0.001). It was concluded that favourable prognosis and syncytial pattern of typical breast medullary carcinomas likely results, at least partly, from a particular expression of cell-cell adhesion molecules, significantly limiting tumour growth and efficiently mastering the tumour cell dissemination, opposing to high proliferative activity (grade 3).

Related Articles

Journal Cover

Aug 1999
Volume 15 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Charpin C, Bonnier P, Garcia S, Andrac L, Crebassa B, Dorel M, Lavaut M and Allasia C: E-cadherin and beta-catenin expression in breast medullary carcinomas.. Int J Oncol 15: 285-377, 1999
APA
Charpin, C., Bonnier, P., Garcia, S., Andrac, L., Crebassa, B., Dorel, M. ... Allasia, C. (1999). E-cadherin and beta-catenin expression in breast medullary carcinomas.. International Journal of Oncology, 15, 285-377. https://doi.org/10.3892/ijo.15.2.285
MLA
Charpin, C., Bonnier, P., Garcia, S., Andrac, L., Crebassa, B., Dorel, M., Lavaut, M., Allasia, C."E-cadherin and beta-catenin expression in breast medullary carcinomas.". International Journal of Oncology 15.2 (1999): 285-377.
Chicago
Charpin, C., Bonnier, P., Garcia, S., Andrac, L., Crebassa, B., Dorel, M., Lavaut, M., Allasia, C."E-cadherin and beta-catenin expression in breast medullary carcinomas.". International Journal of Oncology 15, no. 2 (1999): 285-377. https://doi.org/10.3892/ijo.15.2.285